Phaarmasia Reports Mixed Financial Results Amid Declining Sales and Profitability in August 2025

Phaarmasia, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 11, 2025, indicate a notable shift in the company's evaluation, with the score adjusting to -6 from -4 over the past three months.
The financial data reveals some positive aspects for Phaarmasia. The Debtors Turnover Ratio for the half-yearly period reached its highest level in the last five periods at 7.84 times, suggesting that the company has been effective in settling its debtors more swiftly.

Conversely, the financial results also highlight challenges for Phaarmasia. The net sales for the latest six months amounted to Rs 12.30 crore, reflecting a year-on-year decline of 32.71%. Similarly, the Profit After Tax (PAT) for the same period was recorded at Rs -0.26 crore, also showing a year-on-year decrease of 32.71%. These trends indicate a negative trajectory in both sales and profitability.

For those interested in further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.